These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25452669)

  • 1. The dark side of extracellular ATP in kidney diseases.
    Solini A; Usuelli V; Fiorina P
    J Am Soc Nephrol; 2015 May; 26(5):1007-16. PubMed ID: 25452669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular nucleotide and nucleoside signaling in vascular and blood disease.
    Idzko M; Ferrari D; Riegel AK; Eltzschig HK
    Blood; 2014 Aug; 124(7):1029-37. PubMed ID: 25001468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes.
    Hill LM; Gavala ML; Lenertz LY; Bertics PJ
    J Immunol; 2010 Sep; 185(5):3028-34. PubMed ID: 20668222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degranulation of human mast cells: modulation by P2 receptors' agonists.
    Schulman ES; Nishi H; Pelleg A
    Front Immunol; 2023; 14():1216580. PubMed ID: 37868982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signalling in osteoblasts.
    Gartland A; Orriss IR; Rumney RM; Bond AP; Arnett T; Gallagher JA
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):16-29. PubMed ID: 22201729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.
    Jacob F; Pérez Novo C; Bachert C; Van Crombruggen K
    Purinergic Signal; 2013 Sep; 9(3):285-306. PubMed ID: 23404828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets.
    Filippin KJ; de Souza KFS; de Araujo Júnior RT; Torquato HFV; Dias DA; Parisotto EB; Ferreira AT; Paredes-Gamero EJ
    Purinergic Signal; 2020 Mar; 16(1):1-15. PubMed ID: 31863258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics.
    Guo Y; Mao T; Fang Y; Wang H; Yu J; Zhu Y; Shen S; Zhou M; Li H; Hu Q
    J Adv Res; 2024 Mar; ():. PubMed ID: 38565403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging key roles for P2X receptors in the kidney.
    Birch RE; Schwiebert EM; Peppiatt-Wildman CM; Wildman SS
    Front Physiol; 2013; 4():262. PubMed ID: 24098285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic signalling in the kidney in health and disease.
    Burnstock G; Evans LC; Bailey MA
    Purinergic Signal; 2014 Mar; 10(1):71-101. PubMed ID: 24265071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases.
    Wyss MT; Heuer C; Herwerth M
    Neural Regen Res; 2024 Jun; 19(6):1206-1211. PubMed ID: 37905866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases.
    Chen J; Zhao Y; Liu Y
    Front Immunol; 2014; 5():656. PubMed ID: 25566266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: P2 purinergic receptors regulate the progression of colorectal cancer.
    Zhang WJ; Zhang LP; Lin SJ; Wang CY; Le YG
    Purinergic Signal; 2024 Jun; 20(3):311. PubMed ID: 38427183
    [No Abstract]   [Full Text] [Related]  

  • 14. P2X7 receptor inhibition protects against ischemic acute kidney injury in mice.
    Yan Y; Bai J; Zhou X; Tang J; Jiang C; Tolbert E; Bayliss G; Gong R; Zhao TC; Zhuang S
    Am J Physiol Cell Physiol; 2015 Mar; 308(6):C463-72. PubMed ID: 25588875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein.
    Franceschini A; Capece M; Chiozzi P; Falzoni S; Sanz JM; Sarti AC; Bonora M; Pinton P; Di Virgilio F
    FASEB J; 2015 Jun; 29(6):2450-61. PubMed ID: 25690658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells.
    Sathanoori R; Swärd K; Olde B; Erlinge D
    PLoS One; 2015; 10(5):e0125111. PubMed ID: 25938443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death.
    Toki Y; Takenouchi T; Harada H; Tanuma S; Kitani H; Kojima S; Tsukimoto M
    Biochem Biophys Res Commun; 2015 Mar; 458(4):771-6. PubMed ID: 25681768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer.
    Hofman P; Cherfils-Vicini J; Bazin M; Ilie M; Juhel T; Hébuterne X; Gilson E; Schmid-Alliana A; Boyer O; Adriouch S; Vouret-Craviari V
    Cancer Res; 2015 Mar; 75(5):835-45. PubMed ID: 25564520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
    Antonioli L; Giron MC; Colucci R; Pellegrini C; Sacco D; Caputi V; Orso G; Tuccori M; Scarpignato C; Blandizzi C; Fornai M
    PLoS One; 2014; 9(12):e116253. PubMed ID: 25549098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mouse model of advanced diabetic kidney disease.
    Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
    PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.